Trademark Search in Canada

SYNTHORIN

View On IC.GC.CA

REGISTERED

on 2 Aug 2024

Last Applicant/ Owned by

SYNTHORX INC.

11099 N. Torrey Pines Road Suite 190La Jolla, CA 92037

Serial Number

2035044 filed on 18^th Jun 2020

Registration Number

TMA1247788 registered on 2^th Aug 2024

Registration expiry Date

2^th Aug 2034

Correspondent Address

SMART & BIGGAR LP

SCOTIA PLAZA40 KING STREET WEST40th FLOORTORONTO

ONTARIO

M5H3Y2

SYNTHORIN

Trademark usage description

protein therapeutics expressed, prepared and manufactured using a semi-synthetic organism, namely, pharmaceutical preparations for use in immunologica Read More

Classification Information

Class [005]
Protein therapeutics expressed, prepared and manufactured using a semi-synthetic organism, namely, pharmaceutical preparations for use in immunological disorders, oncology namely, immuno-oncology, cardiovascular diseases, metabolic diseases, namely, diabetes, gout, arthritis and anemia and infectious diseases, namely respiratory infections, eye infections; protein therapeutics expressed, prepared or manufactured using a semi-synthetic organism, namely, proteins designed to deliver highly targeted therapeutic modulation for patients suffering from a variety of diseases, namely, cancer, autoimmune and inflammatory diseases, transplantation and delayed-type hypersensitivity diseases, respiratory diseases, gastrointestinal diseases, cardiovascular and metabolic diseases, pathogen infections, musculoskeletal diseases, ophthalmologic and dermatologic diseases, genitourinary diseases, degenerative diseases, and orphan diseases; protein therapeutics namely, pharmaceutical preparations for use in immunological disorders, rheumatology, namely rheumatoid arthritis and osteoarthritis, oncology, immuno-oncology, pulmonary diseases, gastroenterology, endocrinology, namely, endocrine system diseases and disorders, namely growth and thyroid disorders, dermatology, namely, dermatitis, eczema, urology, gynecology, namely, fertility, infectious diseases, namely, respiratory infections, eye infections, anti-viral agents, ophthalmology, hepatological diseases and disorders, neurological diseases, namely, Alzheimer's, Huntington's Disease, cerebral palsy, and geriatric diseases, namely, arthritis, osteoporosis, and pulmonary hypertension; protein therapeutics, namely, proteins designed to deliver highly targeted therapeutic modulation for patients suffering from cancer and autoimmune disorders; Protein therapeutics, namely, proteins designed to deliver highly targeted therapeutic modulation for patients suffering from a variety of diseases, namely, therapeutic agents in the nature of cytokines, interferons, tumor cell targeting and cytolytic agents, tolerogenic and antiallergic factors, growth and differentiation factors, hormones, replacement enzymes, coagulation factors, lipid binding proteins, anti-infectives, analgesics, and tissue repair factors; non-natural protein modifications for use in connection with a variety of therapeutic areas, namely, protein arrays for medical diagnosis purposes; pharmaceutical preparations, namely, synthetic proteins for use in immunological disorders, rheumatology, namely rheumatoid arthritis and osteoarthritis, oncology, immuno-oncology, pulmonary diseases, gastroenterology, endocrinology, namely, endocrine system, namely growth and thyroid disorders, and neuromuscular diseases, namely primary periodic paralysis, dermatology, namely, dermatitis, eczema, psoriasis, urology, gynecology, namely, fertility, infectious diseases, namely, respiratory infections, eye infections, ophthalmology, hepatological diseases and disorders, neurological diseases, namely, Alzheimer's, Huntington's Disease, cerebral palsy, and geriatric diseases, namely, arthritis, osteoporosis, and pulmonary hypertension.

Classification kind code

Class [042]
Scientific research and laboratory research services in the field of biotechnology; biotechnical research; consulting in the field of biotechnology, bacteriological research, biological research, research and development of new pharmaceutical products and components for third parties, clinical trials, chemical research and analysis services, medical research, pharmaceutical research services.

Classification kind code

Mark Details

Serial Number

2035044

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 190 on 2^th Aug 2024	Registration Pending
Submitted for opposition 42 on 15^th May 2024	Advertised
Submitted for opposition 26 on 18^th Apr 2024	Approved
Submitted for opposition 27 on 18^th Apr 2024	Approval Notice Sent
Submitted for opposition 22 on 2^th Dec 2022	Search Recorded
Submitted for opposition 20 on 2^th Dec 2022	Examiner's First Report
Submitted for opposition 287 on 10^th Jun 2022	Pre-Assessment Letter Sent
Submitted for opposition 30 on 18^th Jun 2020	Filed
Submitted for opposition 1 on 18^th Jun 2020	Created
Submitted for opposition 31 on 18^th Jun 2020	Formalized